These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 940883

  • 1. [Usefulness for differential diagnosis of the distribution of extrapyramidal symptoms resulting from neuroleptic therapy in psychiatric practice].
    Bódog G.
    Psychiatr Neurol Med Psychol (Leipz); 1976 Jan; 28(1):51-7. PubMed ID: 940883
    [Abstract] [Full Text] [Related]

  • 2. Neuroleptic induced extrapyramidal symptoms.
    Donlon PT, Stenson RL.
    Dis Nerv Syst; 1976 Nov; 37(11):629-35. PubMed ID: 136337
    [Abstract] [Full Text] [Related]

  • 3. [Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia].
    Elie R, Gagnon MA, Gauthier R, Jéquier JC.
    Union Med Can; 1975 Jun; 104(6):909-14. PubMed ID: 772906
    [No Abstract] [Full Text] [Related]

  • 4. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.
    Huygens H, Vereecken JL, Tanghe A.
    Psychiatr Neurol Neurochir; 1973 Jun; 76(4):251-9. PubMed ID: 4581374
    [No Abstract] [Full Text] [Related]

  • 5. [Extrapyramidal symptoms following Clozapine therapy. Case report].
    Doepp S, Buddeberg C.
    Nervenarzt; 1975 Oct; 46(10):589-90. PubMed ID: 811999
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The schizophrenias: medical diagnosis and treatment by the family physician.
    Donlon PT.
    J Fam Pract; 1978 Jun; 6(1):71-82. PubMed ID: 621484
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Kinematical analysis of motor function in schizophrenic patients: a possibility to separate negative symptoms from extrapyramidal dysfunction induced by neuroleptics?
    Henkel V, Mergl R, Schäfer M, Rujescu D, Möller HJ, Hegerl U.
    Pharmacopsychiatry; 2004 May; 37(3):110-8. PubMed ID: 15138894
    [Abstract] [Full Text] [Related]

  • 12. [Clinical evaluation of amantadine in the treatment of extrapyramidal syndromes caused by neuroleptic drugs].
    Bukowczyk A, Wasik A, Horodnicki J.
    Psychiatr Pol; 1974 May; 8(2):143-8. PubMed ID: 4830321
    [No Abstract] [Full Text] [Related]

  • 13. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C, Dimascio A, Demirgian E.
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract] [Full Text] [Related]

  • 14. [Present-day possibilities of relieving post-neuroleptic extrapyramidal symptoms].
    Wasik A.
    Psychiatr Pol; 1973 May; 7(1):51-6. PubMed ID: 4715833
    [No Abstract] [Full Text] [Related]

  • 15. [A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
    Gurovich IIa, Fleĭs EP.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969 May; 69(12):1862-8. PubMed ID: 5375563
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Open study with bromperidol (C-C 2489), a new neuroleptic, for the determination of the neuroleptic threshold and the neuroleptic-therapeutic range.
    Haase HJ, Kaumeier S, Schwarz H, Gundel A, Linde OK, Maetz H, Scheel R, Stripf A, Stripf L.
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Mar; 11(2):81-5. PubMed ID: 643910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.